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Background: Adolescent girls are at an age to be involved in the decision about HPV vaccination uptake and
therefore need adequate information about the vaccination. This study assesses to what extent reading an official
information leaflet about HPV contributes to girls’ knowledge levels, and to what extent an increase in knowledge
is boosted by a pre-test measurement.
Methods: Participants (girls aged 11–14 years) were systematically allocated to group A that completed a pre-test
measurement (12 true/false statements) or to group B that did not complete it. Subsequently, both groups read the
HPV leaflet and completed the post-test measurement.
Results: The response rate was 237/287 (83%). Pre-test scores in group A (M = 3.6, SD = 1.81, p < 0.001) were lower
than post-test mean knowledge scores (0–10) in group B (M = 4.6, SD = 2.05). Post-test knowledge scores in group
A were higher than those in group B [6.2 (SD = 2.06) versus 4.6 (SD = 2.05), p < 0.001]. In the post-test measurement,
about a third of both groups knew that vaccinations do not give 100% protection against cervical cancer and that
the duration of protection is unknown.
Conclusions: Reading the information leaflet had a positive effect on knowledge, even more so when boosted by
a pre-test measurement. However, knowledge on the degree and duration of protection against cervical cancer
remained limited. Focusing girls’ attention on important aspects before they start reading the leaflet
(e.g. by including a quiz on the first page) may serve to raise their awareness of these aspects.
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Young adolescent girls are at an age to be involved in
decisions about vaccination uptake. Countries like the
United Kingdom, Canada, Australia and the Netherlands
offer human papillomavirus (HPV) vaccine to girls at an
age between 11 and 14 years. Girls need access to adequate
information about HPV and the vaccination to be well
informed about the risks/benefits of the vaccination. How-
ever, decisions about uptake are often made without suffi-
cient information [1]. It is important that girls know, for
example, that: HPV is transmitted through sexual activity* Correspondence: r.hofman@erasmusmc.nl
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reproduction in any medium, provided the orand has a lifetime risk of 75-80% [2,3]; that although HPV
infections are common, most infections clear within 2 years
[4,5]; that an HPV infection is a necessary factor in the
development of cervical cancer [6]; and that the vaccine
does not provide full protection against HPV infections
(it does protect against HPV 16 and 18 which are respon-
sible for 71% of all cervical cancers [7]). Furthermore, a
positive association has been found between knowledge on
HPV and uptake [8,9].
Although knowledge on vaccine has been assessed
among women [10-12] and adolescents [13], the impact
of official information leaflets on knowledge among young
adolescents has not yet been examined. This study assesses
i) the extent to which girls’ knowledge levels about HPV
vaccination increase after reading the official leaflet that alll Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Study design in answering the two research questions.
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offer, and ii) to what extent an increase in knowledge may
be boosted by a pre-test measurement.
Methods
Participants
Girls aged 11–14 years were recruited from three secondary
public schools (state funded: one urban, two rural), whilst
attending their first year there. One of the authors
(PAWHS) approached schools in different regions by tele-
phone and asked if they were willing to cooperate. The
number of participants was based on feasibility; however, a
post-hoc power analysis showed that the power was 0.992.
Design
In the Netherlands girls are offered the bivalent vaccine
against HPV. All girls eligible for HPV vaccination re-
ceive an information leaflet about HPV and vaccination
characteristics, sent by mail to their home address by
the municipal health service. The leaflet includes infor-
mation on how HPV is spread, the incidence of cervical
cancer, the degree/duration of protection of the vaccine,
the risk and symptoms of mild side-effects, and the need
of a pap smear in both vaccinated and unvaccinated
women. To assess girls’ knowledge levels about HPV
and HPV vaccination after reading this information leaflet,
we asked girls to read the leaflet (in their classroom) and
to then complete a post-test measurement.
To assess the increase in girls’ knowledge levels about
HPV vaccination, we needed to know the pre-reading
knowledge levels and introduced a pre-test measurement.
Since we acknowledged that a pre-test measurement
could prompt more attentive reading of the leaflet
and boost knowledge increase, a second group was intro-
duced that did not complete a pre-test measurement. This
resulted in the following design with equal numbers in both
groups: girls present in the classroom were assigned to ei-
ther group A (seated at one side of the classroom) which
completed a pre-test measurement, then read the leaflet
and immediately completed a post-test measurement; or
group B (seated at the other side of the classroom)
which read the leaflet and then completed the post-test
measurement. There was no follow-up time between com-
pleting all the measurements and reading the leaflet.
To assess to what extent the girls’ knowledge levels
about HPV vaccination increased after reading the leaflet,
we compared knowledge scores of the pre-test measurement
of group A with the post-test measurement of group B
(Figure 1), assuming that the demographic characteristics of
group A and B were similar. We hypothesized that the total
knowledge score would increase after reading the leaflet.
To assess the effect of a pre-test measurement, prompting
more attentive reading of the leaflet and boosting knowledge
increase, we compared the post-test measurements of groupA and B (Figure 1). We hypothesized that, after reading the
leaflet, the total knowledge score of group A would be
higher than that of group B.
It should be noted that in addressing the first research
question the pre-test measurement serves as an assess-
ment and the leaflet is interpreted as the intervention,
whereas in addressing the second research question the
pre-test measurement and the leaflet combined serve as
the intervention (Figure 1).
Procedure
The study was performed in accordance with the Declar-
ation of Helsinki and was approved by the Medical Ethics
Committee of Erasmus MC (MEC-2010-328). The parents
of potentially participating girls received an information
letter about the study and an opt-out form. Questionnaires
were completed in December 2010 and January 2011 and
were distributed to participants in their classrooms. A
brief introduction was given on the process of completing
questionnaires and reading the leaflet. Completion and
reading together took 25–40 min.
Questionnaire
The self-administered questionnaire (Additional file 1)
assessed knowledge on HPV vaccination and demographic
characteristics. Before presenting the questionnaire to the
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children and one teacher to evaluate its comprehensibility.
Knowledge was assessed through 12 statements (Table 1).
We considered eight of these statements to be essential
aspects of vaccination, such as the degree/duration of pro-
tection against HPV through vaccination, and transmis-
sion of the virus. The remaining four items addressed
details of the HPV vaccination, such as costs of vaccin-
ation and permission for vaccination. The correct answer
to each statement could be found in the leaflet. Answer
options were ‘absolutely true’, ‘possibly true’, ‘possibly not
true’ and ‘absolutely not true’. We choose this response
system to be able to assess respondents’ uncertainty
about their answers and to assess knowledge increase at
a detailed level, i.e. the percentage of respondents in
group A who were not sure about their answer before
reading the leaflet (marked possibly true or not true)
and were sure about the correct answer after reading
the leaflet (marked ‘absolutely true or not true’) (Table 1).
If a statement was true the following points were assigned:
absolutely true: 1 point, possibly true: 0 points, possibly
not true: 0 points, and absolutely not true: 0 points. If a
statement was not true, then the following points were
assigned: absolutely not true: 1 point, possibly not true: 0
points, possibly true: 0 points, and absolutely true: 0
points. To facilitate interpretation of the total knowledge
score, results were transformed to a 0–10 scale.Table 1 Comparison of knowledge scores between group A a
No. Statement
1 HPV vaccinations completely protect against cervical cancer (false).
2 Even if you only have safe sex you can be infected with HPV (true).
3 All 12-year-old girls will be sent an invitation for HPV vaccinations
without having to ask for it (true).
4 Legally, parents need to give permission for HPV vaccinations
in 12-year-olds (false).
5 In spite of HPV vaccinations, Pap-smears from age≥ 30 years
are still recommended (true).
6 You can only have a Pap smear if you have first had HPV
vaccinations (false).
7 HPV vaccinations can make you lose your hair (false).
8 If you have been sexually active HPV vaccinations are still advised (true)
9 HPV vaccinations reduce the risk of getting cervical cancer (true).
10 We know for a fact that HPV vaccinations protect against cervical
cancer for a lifetime (false).
11 HPV vaccinations reduce the risk of dying of cervical cancer (true).
12 HPV vaccinations require several hundred dollars out-of-pocket
expenses (false).
1a Percentage of correct answers in the post-test measurement in group B was significa
1b Percentage of correct answers in the post-test measurement in group B was significa
2 Percentage of correct answers in the post-test measurement in group A was significaIn addition, we asked girls if they were already vaccinated
against HPV. If girls had not been vaccinated, we addressed
their intention to get vaccinated against HPV on a 10-point
Likert scale (1 = definitely not, 10 = definitely) with the
following question: ‘Do you intend to get vaccinated
against HPV?’
Analyses
First, to assess whether knowledge on HPV vaccination
increased after reading the leaflet, an independent
samples t-test was used to analyse the difference in total
knowledge scores between the pre-test measurement of
group A and the post-test measurement of group B. Sec-
ond, to assess to what extent an increase in knowledge was
boosted by a pre-test measurement, an independent sam-
ples t-test was used to assess differences in total knowledge
scores between the post-test measurements of group A and
B. We assumed that pre-test knowledge levels would be
similar in both groups. Cohen’s effect sizes were calculated
[14]. Third, Chi-square tests were used to assess whether
the number of correct answers per statement differed
significantly between the pre-test measurement of group A
and the post-test measurement of group B, and between
the post-test measurements of both groups (Table 1). Dif-
ferences between group A and B in background variables
were assessed using Mann–Whitney U tests for continuous
variables and Chi-square tests for categorical variables.nd group B and within group A
Pre-test group A vs.
post-test group B
Post-test group A vs.
post-test group B
Group A: ‘almost
correct’ at pre-test to
‘absolutely correct’
at post-test
p-value n (%)
0.0031a 0.169 9 (7.6)
0.0011a 0.079 32 (26.9)
0.851 0.0072 18 (15.1)
<0.0011a 0.054 8 (6.7)
<0.0011a <0.0012 62 (52.1)
0.148 0.0032 16 (13.4)
<0.0011a 0.0132 40 (33.6)
. 0.265 0.0022 37 (31.1)
0.0061b <0.0012 18 (15.1)
0.175 0.319 18 (15.1)
0.456 <0.0012 26 (21.8)
0.131 0.999 21 (17.6)
ntly higher compared to the pre-test measurement in group A.
ntly lower compared to the pre-test measurement in group A.
ntly higher compared to the post-test measurement in group B.
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Participants
The response rate was 237/287 (83%). Non-participation was
due to absenteeism from school or lack of parental consent
to participate. The mean age of the participants was 12.2 (SD
group A = 0.50, SD group B = 0.45) years and almost all
participants were born in the Netherlands (group A: 96.6%;
group B: 94.9%). The majority of participants had high
(group A: 41.2%; group B: 39.0%) or intermediate (group
A: 34.4%; group B: 39.0%) educational level (Dutch schools
have different educational levels within a school year).
About half of the participants stated they had a religious
affiliation (group A: 55.6%; group B: 50%). Group A and B
showed no significant differences regarding demographic
characteristics and HPV vaccination history (Table 2).
Comparison of knowledge scores before and after
reading the leaflet
For these analyses, total knowledge scores of the pre-test
measurement of group A (n = 119) were compared withTable 2 Characteristics of the study participants
Characteristics G
(
Mean
Age (years) (12.2)
Age range (years) 11-14
n
Educational level
Low 29
Intermediate 41
High 49
Religion
None 52
Christian 64
Islam 1
Other 0
Country of birth of participants
The Netherlands 115
Country of birth of parents
Both parents born in the Netherlands 102
One parent born outside the Netherlands 9
Both parents born outside the Netherlands 7
HPV vaccinated before completion of questionnaire
Yes 22
Intention if not vaccinated
Low 12
Neutral 18
High 66
Note: Group A and B had no significant differences regarding demographic characteristhe scores of the post-test measurement of group B
(n = 118). As hypothesized, we found that total knowledge
scores were significantly lower in group A before reading
the leaflet (M = 3.6, SD = 1.81) than in group B that
completed the questionnaire after (M = 4.6, SD = 2.05)
reading the leaflet, t(235) = −3.941, p < 0.001. Cohen’s effect
size was 0.52, indicating a moderate effect [14]. Figure 2
shows the distribution of correct answers per knowledge
statement about HPV and cervical cancer.
The number of correct answers to 5 of 12 statements
was significantly lower in group A (n = 119) before reading
the leaflet than in group B (n = 118) after reading the leaflet.
For instance, statement 2 about safe sex and infection
[group A: 25/119 (21.0%), group B: 50/118 (42.4%); p =
0.001], statement 1 about incomplete protection against
cervical cancer [group A: 12/119 (10.1%), group B: 30/118
(25.4%); p = 0.003], and statement 10 about unknown
duration of protection against cervical cancer [group A: 18/
119 (15.1%), group B: 27/118 (22.9%); p = 0.175]. However,
statement 9 about the risk reduction of getting cervicalroup A Group B
n = 119) (n = 118) p-value
(SD) Mean (SD)
(0.50) (12.2) (0.45) 0.82
11-13
(%) n (%)
0.76
(24.4) 26 (22.0)
(34.4) 46 (39.0)
(41.2) 46 (39.0)
0.40
(44.4) 59 (50.0)
(54.7) 56 (47.5)
(0.9) 1 (0.8)
(0.0) 2 (1.7)
0.74
(96.6) 112 (94.9)
0.75
(86.4) 97 (86.6)
(7.6) 9 (8.0)
(5.9) 6 (5.4)
(18.5) 17 (14.5) 0.52
0.26
(12.5) 21 (21)
(18.8) 19 (19)
(68.7) 60 (60)
tics and HPV vaccination history.
Figure 2 Percentage of correct answers to the statements made by group A and B.
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often by group B after reading the leaflet than by group A
before reading the leaflet (pre: 78.2%, post: 61.0%; p = 0.006)
(Figure 2) (Table 1).
We assessed the number of respondents in group A who
had an ‘almost correct’ answer before reading the leaflet
and an ‘absolutely correct’ answer after reading the leaflet.
Respondents were most reassured by the leaflet about the
correct answer considering the following statements: state-
ment 5 about the recommendation of pap smears in spite
of HPV vaccination 62/119 (52.1%); statement 7 about hair
loss after vaccination 40/119 (33.6%); and statement 8 about
sexual activity and vaccination 37/119 (31.1%) (Table 1).
Influence of pre-test measurement on knowledge scores
at post-test measurement
Comparing knowledge scores of both post-tests between
group A and B showed, as hypothesized, that group A
(n = 119) (M = 6.2, SD = 2.06) had a significantly higher total
knowledge score at the post-test measurement than group
B (n = 118) (M = 4.6, SD = 2.05), t(235) = 5.805, p < 0.001).
Cohen’s effect size was 0.78, indicating a moderate effect
[14]. After completing a pre-test measurement and reading
the leaflet (group A), the number of correct answers to 7 of
12 statements was significantly larger than after reading the
leaflet only (group B) (Table 1).Discussion
This study examined the knowledge among girls aged
11–14 years about HPV and vaccination, and the extent
of increase in knowledge after reading the official HPV
vaccination leaflet used in the Dutch national immunization
program. Firstly, total knowledge scores were higher after
reading the information leaflet and we conclude that read-
ing it had a positive effect on the knowledge levels of
the girls. Secondly, post-leaflet total knowledge scores
were higher in girls who had also completed the question-
naire before reading the leaflet and we conclude that
completing this questionnaire had a positive effect on the
knowledge levels.
Inclusion of a second group that did not complete a
pre-test allowed to assess the effect of a pre-test measure-
ment on knowledge scores. The characteristics of both
groups were similar, indicating that systematically dividing
the girls into two groups worked well and the groups were
comparable. The higher post-leaflet knowledge scores in
girls who had also completed the questionnaire before
reading the leaflet are probably due to the girls’ attention
being prompted by the statements in the questionnaire,
and their increased awareness of the knowledge they were
supposed to have at the post-test measurement. This may
have led to more attentive reading of the leaflet and thus
being able to answer more statements correctly. Such a
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an intervention, is called the mere measurement effect
[15]. This effect was also found in a study among novice
blood donors; people who completed a questionnaire
about blood donation were more willing to give blood
than those who had not completed a questionnaire [15].
The percentage of correct answers to some statements
largely increased from a low percentage before reading
the leaflet to a high percentage after reading the leaflet,
e.g. the statements about whether girls need permission
from their parents to get vaccinated and that, despite
HPV vaccinations, pap smears are still recommended. The
leaflet had a positive effect on increased knowledge scores
after reading it. Because some statements were already
answered correctly by most girls before reading the leaflet,
there was less room for improvement in knowledge. Sur-
prisingly, knowledge on the degree/duration of protection
against cervical cancer was low before reading the leaflet
and remained relatively low after reading it. For instance,
about 75% of the girls incorrectly thought that vaccination
completely protects against cervical cancer and that protec-
tion lasts a lifetime. For optimal benefit from HPV vaccin-
ation, girls need to know that booster vaccinations might
be needed in the future and that other preventive measures,
such as screening, are still recommended. We advise
additional education about the recommendation to partici-
pate in cervical cancer screening also after HPV vaccin-
ation. The group who completed the statements before and
after reading the leaflet had better knowledge scores at the
post-test measurement regarding all statements. With the
exception of one statement, knowledge on the risk reduc-
tion of getting cervical cancer after HPV vaccination was
worse after reading the leaflet in one group than before
reading the leaflet in the other group. A possible ex-
planation for this might be that girls who completed
the pre-test measurement were better informed about
HPV vaccination before completing the pre-test and
reading the leaflet; however, their knowledge on this
item increased after reading the leaflet. For this reason,
we suggest that this specific item be thoroughly revised
when the leaflet is e.g. updated.
We acknowledge that it is preferable to use larger
groups, and to randomise in a more sophisticated way
than simply dividing one side of the classroom from the
other. Overall, to improve girls’ understanding of the pur-
pose of vaccination and the degree/duration of protection
against cervical cancer, we recommend that information be
unambiguous and that the key points should be clearly
outlined on a prioritized list [16]. This can be achieved by,
e.g., editing or improving the current leaflet, or offering
information on these important aspects at school or other
relevant locations.
A limitation is that we only have data on the girls’
intention to have (or not have) the vaccination, and lackinformation on the actual decision about uptake. Strengths
of the study are its external validity: the use of an official
leaflet which is sent to every 12-year-old girl in the
Netherlands, the high response rate (83%), and the fact that
the leaflet addresses a choice that participants have to make
in real life. However, reading the leaflet at school is different
from reading it at home and, due to non-probability sam-
pling; the results may not represent the entire population.
Conclusion
This study shows that reading the information leaflet
had a positive effect on girls’ knowledge about HPV,
which showed a further increase when boosted by a pre-
test measurement. However, levels of knowledge regarding
the degree/duration of protection against cervical cancer
remained low. Prompting girls’ attention before they start
reading the leaflet may raise their awareness of important
aspects of HPV vaccination and may give better support in
their decision-making process. This could, for example, be
organized by conducting a quiz at school, by including a
quiz on the first page of the leaflet, or by conducting a quiz
on the internet which has the advantage of being able to
provide tailored information based on a girl’s knowledge
score.
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